News Announcement

Aurobindo Pharma: Board Meeting Outcome for Outcome Of Board Meeting

In accordance with the provisions of Regulations 30 and all other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that the Board of Directors of the Company at its meeting held today November 9 2024 has inter alia considered and approved the standalone and consolidated Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2024 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. We enclose herewith the said Unaudited Financial Results of the Company along with the Limited Review Reports issued by the Statutory Auditors.


दूसरी कैटेगरी